Literature DB >> 29460345

Comparative virulence of Candida auris with Candida haemulonii, Candida glabrata and Candida albicans in a murine model.

Hamed Fakhim1,2, Afsane Vaezi3,4, Eric Dannaoui5, Anuradha Chowdhary6, Davood Nasiry7, Leila Faeli3,4, Jacques F Meis8,9, Hamid Badali4.   

Abstract

The incidence of invasive fungal infections (IFIs) caused by uncommon Candida species with diverse virulence and susceptibility profiles has increased in recent years. Due to scarce clinical and experimental data on the pathogenicity of Candida auris, the aim of this study was to evaluate and compare the virulence of two rare clinically relevant species, C. auris and Candida haemulonii with Candida glabrata and Candida albicans in an immunocompetent murine model of disseminated infection. Immunocompetent ICR female mice were infected with three inoculum sizes (1 × 105 , 1 × 106 and 1 × 107 CFU/mouse) of two C. auris strains and one isolate of C. haemulonii, C. glabrata and C. albicans. Tissue burden on days 5 and 10 postchallenge and mortality rate were used as virulence markers. A high virulence was found for C. albicans, followed by C. auris, C. glabrata and C. haemulonii, respectively. Candida albicans showed high virulence with a medium survival time of 9.5 days for mice infected with 1 × 107 CFU/mouse. For inocula at 1 × 106 and 1 × 107 CFU/mouse, there were significant differences in fungal burden at day 10 between C. albicans, C. auris and C. glabrata isolates compared with C. haemulonii (P < .0001). Overall, no significant differences between C. albicans with C. auris and C. glabrata were observed in mice infected with three different inocula (P > .05). In general, the highest fungal load of all isolates was detected in kidney followed by spleen, liver and lung tested with three different inocula on the two different experimental days. Histopathological examination revealed the abundant presence of yeast cells with pseudohyphae for C. albicans and only yeast cells for C. auris, C. glabrata and C. haemulonii, in all the kidney tissue samples. In conclusion, C. albicans is a highly virulent opportunistic fungus, as the clinical and experimental data demonstrate, and also our results demonstrate a low virulence of C. haemulonii in immunocompetent animals. Altogether, this study highlights the pathogenic potential of C. auris.
© 2018 Blackwell Verlag GmbH.

Entities:  

Keywords:  zzm321990Candida auriszzm321990; disseminated candidiasis; murine model; pathogenicity; survival study; tissue burden

Mesh:

Year:  2018        PMID: 29460345     DOI: 10.1111/myc.12754

Source DB:  PubMed          Journal:  Mycoses        ISSN: 0933-7407            Impact factor:   4.377


  33 in total

1.  Caenorhabditis elegans as a Model System To Assess Candida glabrata, Candida nivariensis, and Candida bracarensis Virulence and Antifungal Efficacy.

Authors:  Ainara Hernando-Ortiz; Estibaliz Mateo; Marcelo Ortega-Riveros; Iker De-la-Pinta; Guillermo Quindós; Elena Eraso
Journal:  Antimicrob Agents Chemother       Date:  2020-09-21       Impact factor: 5.191

2.  Drosophila melanogaster as a model to study virulence and azole treatment of the emerging pathogen Candida auris.

Authors:  Sebastian Wurster; Ashwini Bandi; Nicholas D Beyda; Nathaniel D Albert; Nitya M Raman; Isaam I Raad; Dimitrios P Kontoyiannis
Journal:  J Antimicrob Chemother       Date:  2019-07-01       Impact factor: 5.790

Review 3.  Candida auris: a fungus with identity crisis.

Authors:  Taissa Vila; Ahmed S Sultan; Daniel Montelongo-Jauregui; Mary Ann Jabra-Rizk
Journal:  Pathog Dis       Date:  2020-06-01       Impact factor: 3.166

4.  Impact of Candida auris Infection in a Neutropenic Murine Model.

Authors:  Steven R Torres; Amber Pichowicz; Fernando Torres-Velez; Renjie Song; Navjot Singh; Erica Lasek-Nesselquist; Magdia De Jesus
Journal:  Antimicrob Agents Chemother       Date:  2020-02-21       Impact factor: 5.191

5.  Activity of anti-CR3-RP polyclonal antibody against biofilms formed by Candida auris, a multidrug-resistant emerging fungal pathogen.

Authors:  Jaroslava Dekkerová; Jose L Lopez-Ribot; Helena Bujdáková
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-10-16       Impact factor: 3.267

6.  Candida auris Clinical Isolates from South Korea: Identification, Antifungal Susceptibility, and Genotyping.

Authors:  Yong Jun Kwon; Jong Hee Shin; Seung A Byun; Min Ji Choi; Eun Jeong Won; Dain Lee; Seung Yeob Lee; Sejong Chun; Jun Hyung Lee; Hyun Jung Choi; Seung Jung Kee; Soo Hyun Kim; Myung Geun Shin
Journal:  J Clin Microbiol       Date:  2019-03-28       Impact factor: 5.948

7.  In vitro and in vivo photodynamic efficacies of novel and conventional phenothiazinium photosensitizers against multidrug-resistant Candida auris.

Authors:  Patrícia Helena Grizante Barião; Ludmilla Tonani; Guilherme Thomaz Pereira Brancini; Erika Nascimento; Gilberto Úbida Leite Braga; Mark Wainwright; Marcia Regina von Zeska Kress
Journal:  Photochem Photobiol Sci       Date:  2022-07-11       Impact factor: 4.328

8.  Murine model of colonization with fungal pathogen Candida auris to explore skin tropism, host risk factors and therapeutic strategies.

Authors:  Xin Huang; Charlotte Hurabielle; Rebecca A Drummond; Nicolas Bouladoux; Jigar V Desai; Choon K Sim; Yasmine Belkaid; Michail S Lionakis; Julia A Segre
Journal:  Cell Host Microbe       Date:  2020-12-31       Impact factor: 21.023

9.  Adaptation of the emerging pathogenic yeast Candida auris to high caspofungin concentrations correlates with cell wall changes.

Authors:  Violeta Lara-Aguilar; Cristina Rueda; Irene García-Barbazán; Sarai Varona; Sara Monzón; Pilar Jiménez; Isabel Cuesta; Ángel Zaballos; Óscar Zaragoza
Journal:  Virulence       Date:  2021-12       Impact factor: 5.882

10.  Genotyping, antifungal susceptibility, enzymatic activity, and phenotypic variation in Candida albicans from esophageal candidiasis.

Authors:  Hadis Jafarian; Maral Gharaghani; Seyed Saeed Seyedian; Ali Zarei Mahmoudabadi
Journal:  J Clin Lab Anal       Date:  2021-05-14       Impact factor: 2.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.